ACTRN12621001588886招募中未知
Oestradiol PET scans in metastatic breast cancer:investigation of utility of assessing disease burden and treatment response
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •ER positive metastatic breast cancer patient as defined as IHC >30% for ER who are either treatment naïve in the metastatic setting, or who have been determined to have progressed on previous treatment and are planned to commence a further line of treatment. Those with either ductal or lobular subtype will be included. The number of ductal patients included will be capped at five.
排除标准
- •Life expectancy less than 6 months, unable to give informed consent, unable to comply with required scanning schedule. May include conditions that increase the risk to the participant, that interfere with the participants ability to give informed consent or interfere with a participant’s ability to comply.
研究者
相似试验
终止
不适用
Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast CancerMetastatic Breast CancerNCT00358098AHS Cancer Control Alberta51
进行中（未招募）
1 期
Basket study for oligo-metastatic breast cancer - ANISEbreast cancer, HER2-positive, oligometastatic diseaseMedDRA version: 20.1Level: PTClassification code: 10055113Term: Breast cancer metastatic Class: 100000004864MedDRA version: 23.0Level: PTClassification code: 10065430Term: HER2 positive breast cancer Class: 100000004864CTIS2023-505039-11-00Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis72
尚未招募
不适用
Improving treatments for brain metastases through advanced imagingbrain metastasesmetastatic breast cancerACTRN12618000803291The University of Queensland20
进行中（未招募）
2 期
18F-fluoroestradiol (FES) PET/CT for Breast CancerBreast CancerNCT04883814Hoag Memorial Hospital Presbyterian124
已完成
早期 1 期
Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor StatusBreast CancerNCT01916122Memorial Sloan Kettering Cancer Center54